⌘K

Login Start Free

Home/Filings/4/0001181431-14-006068

4//SEC Filing

MEDNAX, INC. 4

Accession 0001181431-14-006068

$MDCIK 0000893949operating

View on SEC.gov Company Profile

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 7:15 PM ET

Size

22.5 KB

Accession

0001181431-14-006068

Insider Transaction Report

Form 4

Period: 2014-02-06

CALABRO JOSEPH M

President and COO

Transactions

Sale
Common Stock
2014-02-07$55.20/sh−55,282$3,051,522→ 226,542 total
Exercise/Conversion
Common Stock
2014-02-07$22.35/sh+55,282$1,235,553→ 281,824 total
Exercise/Conversion
Common Stock
2014-02-10$27.71/sh+87,500$2,425,063→ 314,261 total
Sale
Common Stock
2014-02-10$55.82/sh−87,719$4,896,045→ 226,542 total
Exercise/Conversion
Stock Option (Right to Buy)
2014-02-10$27.71/sh−87,500$2,425,063→ 62,500 total
Exercise: $27.71From: 2011-06-02Exp: 2018-06-02→ Common Stock (87,500 underlying)
Exercise/Conversion
Common Stock
2014-02-06$22.35/sh+6,999$156,428→ 233,541 total
Sale
Common Stock
2014-02-06$55.03/sh−6,999$385,176→ 226,542 total
Exercise/Conversion
Stock Option (Right to Buy)
2014-02-07$22.35/sh−55,282$1,235,553→ 219 total
Exercise: $22.35From: 2009-06-01Exp: 2016-06-01→ Common Stock (55,282 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2014-02-06$22.35/sh−6,999$156,428→ 55,501 total
Exercise: $22.35From: 2009-06-01Exp: 2016-06-01→ Common Stock (6,999 underlying)
Exercise/Conversion
Common Stock
2014-02-10$22.35/sh+219$4,895→ 226,761 total
Exercise/Conversion
Stock Option (Right to Buy)
2014-02-10$22.35/sh−219$4,895→ 0 total
Exercise: $22.35From: 2009-06-01Exp: 2016-06-01→ Common Stock (219 underlying)

Holdings

Common Stock
(indirect: By Spouse)
8

Footnotes (5)

[F1]Sales made pursuant to Reporting Person's 10b5-1 trading plan.
[F2]Sales of shares were executed in eleven (11) separate transactions with prices ranging from $55.00 to $55.10 for a weighted average sales price of $55.03.
[F3]Sales of shares were executed in thirty-nine (39) separate transactions with prices ranging from $55.00 to $55.38 for a weighted averages sales price of $55.1992.
[F4]Sales of shares were executed in one hundred seventeen (117) separate sales with prices ranging from $55.02 to $56.41 for a weighted average sales price of $55.8151.
[F5]All share amounts and exercise prices have been adjusted to reflect the Issuer's 2-for-1 stock split effective December 19, 2013.

Documents

1 file

4
rrd401812.xmlPrimary

Issuer

MEDNAX, INC.

CIK 0000893949

Entity typeoperating

IncorporatedFL

Related Parties

1

filerCIK 0000893949

Filing Metadata

Form type: 4
Filed: Feb 9, 7:00 PM ET
Accepted: Feb 10, 7:15 PM ET
Size: 22.5 KB

View on SEC.gov